ArticleDermatology (Basel, Switzerland)2022

Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis.

Georgios Kokolakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.